The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
gp100/pmel 17 Is a Murine Tumor Rejection Antigen: Induction of “Self”-reactive, Tumoricidal T Cells Using High-affinity, Altered Peptide Ligand
Open accessAbstract
Many tumor-associated antigens are nonmutated, poorly immunogenic tissue differentiation antigens. Their weak immunogenicity may be due to “self”-tolerance. To induce autoreactive T cells, we studied immune responses to gp100/pmel 17, an antigen naturally expressed by both normal melanocytes and melanoma cells. Although a recombinant vaccinia virus (rVV) encoding the mouse homologue of gp100 was nonimmunogenic, immunization of normal C57BL/6 mice with the rVV encoding the human gp100 elicited a specific CD8+ T cell response. These lymphocytes were cross-reactive with mgp100 in vitro and treated established B16 melanoma upon adoptive transfer. To understand the mechanism of the greater immunogenicity of the human version of gp100, we characterized a 9-amino acid (AA) epitope, restricted by H-2Db, that was recognized by the T cells. The ability to induce specific T cells with human but not mouse gp100 resulted from differences within the major histocompatibility complex (MHC) class I–restricted epitope and not from differences elsewhere in the molecule, as was evidenced by experiments in which mice were immunized with rVV containing minigenes encoding these epitopes. Although the human (hgp10025–33) and mouse (mgp10025–33) epitopes were homologous, differences in the three NH2-terminal AAs resulted in a 2-log increase in the ability of the human peptide to stabilize “empty” Db on RMA-S cells and a 3-log increase in its ability to trigger interferon γ release by T cells. Thus, the fortuitous existence of a peptide homologue with significantly greater avidity for MHC class I resulted in the generation of self-reactive T cells. High-affinity, altered peptide ligands might be useful in the rational design of recombinant and synthetic vaccines that target tissue differentiation antigens expressed by tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
T cell tolerance by clonal elimination in the thymus
Kappler, J. W., Roehm, N., & Marrack, P. (1987) · Cell · doi:10.1016/0092-8674(87)90568-x · Cited by 2,211
Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
Self-citationMHC ligands and peptide motifs: first listing
Rammensee, H.-G., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638
Parker, K. C., Bednarek, M. A., & Coligan, J. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.1.163 · Cited by 1,370
Empty MHC class I molecules come out in the cold
Ljunggren, H.-G., Stam, N. J., Öhlén, C., Neefjes, J. J., Höglund, P., Heemels, M.-T., Bastin, J., Schumacher, T. N. M., Townsend, A., Kärre, K., et al. (1990) · Nature · doi:10.1038/346476a0 · Cited by 926
Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6458 · Cited by 914
Self-citationB Cells Turn Off Virgin But Not Memory T Cells
Fuchs, E. J., & Matzinger, P. (1992) · Science · doi:10.1126/science.1439825 · Cited by 562
Parkhurst, M. R., Salgaller, M. L., Southwood, S., Robbins, P. F., Sette, A., Rosenberg, S. A., & Kawakami, Y. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2539 · Cited by 556
Self-citationKawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P. F., Sette, A., Appella, E., & Rosenberg, S. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3961 · Cited by 540
Self-citationTumor antigens recognized by T cells
Boon, T., Coulie, P. G., & Van den Eynde, B. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)80020-5 · Cited by 537
Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.
Moss, B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11341 · Cited by 515
Self-citationLow avidity recognition of self-antigen by T cells permits escape from central tolerance
Liu, G. Y., Fairchild, P. J., Smith, R. M., Prowle, J. R., Kioussis, D., & Wraith, D. C. (1995) · Immunity · doi:10.1016/1074-7613(95)90170-1 · Cited by 413
Compact, Synthetic, Vaccinia Virus Early/Late Promoter for Protein Expression
Chakrabarti, S., Sisler, J. R., & Moss, B. (1997) · BioTechniques · doi:10.2144/97236st07 · Cited by 389
Self-citationCancer vaccines based on the identification of genes encoding cancer regression antigens
Rosenberg, S. A. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)84664-6 · Cited by 386
Self-citationVanderlugt, C. J., & Miller, S. D. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80012-4 · Cited by 331
A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus.
Jackson, I. J., Chambers, D. M., Tsukamoto, K., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., & Hearing, V. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05083.x · Cited by 322
Preparation of Cell Cultures and Vaccinia Virus Stocks
Earl, P. L., Cooper, N., Wyatt, L. S., Moss, B., & Carroll, M. W. (1998) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps0512s13 · Cited by 282
Self-citationSimitsek, P. D., Campbell, D. G., Lanzavecchia, A., Fairweather, N., & Watts, C. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.6.1957 · Cited by 267
Schwartz, R. H. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80081-7 · Cited by 255
Cloning and expression of cDNA encoding mouse tyrosinase
Shibahara, S., Torruta, Y., Sakakura, T., Nager, C., Chaudhuri, B., & Müller, R. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.6.2413 · Cited by 239
Irvine, K. R., Rao, J. B., Rosenberg, S. A., & Restifo, N. P. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.238 · Cited by 233
Self-citationB cells process and present lupus autoantigens that initiate autoimmune T cell responses.
Mamula, M. J., Fatenejad, S., & Craft, J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.3.1453 · Cited by 229
Antigen processing in vivo and the elicitation of primary CTL responses.
Restifo, N. P., Bacík, I., Irvine, K. R., Yewdell, J. W., McCabe, B. J., Anderson, R. W., Eisenlohr, L. C., Rosenberg, S. A., & Bennink, J. R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4414 · Cited by 217
Self-citationDeng, Y., Yewdell, J. W., Eisenlohr, L. C., & Bennink, J. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1507 · Cited by 199
Mamula, M. J., Lin, R. H., Janeway, C. A., & Hardin, J. A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.3.789 · Cited by 172
Eiseniohr, L. C., Bačík, I., Bennink, J. R., Bernstein, K. E., & Yewdell, J. W. (1992) · Cell · doi:10.1016/0092-8674(92)90392-p · Cited by 152
Bronte, V., Carroll, M. W., Goletz, T. J., Wang, M. L., Overwijk, W. W., Marincola, F. M., Rosenberg, S. A., Moss, B., & Restifo, N. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3183 · Cited by 139
Self-citationMoudgil, K. D., Chang, T. T., Eradat, H. A., Chen, A. M., Gupta, R. S., Brahn, E., & Sercarz, E. E. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.7.1307 · Cited by 139
The Pmel 17/silver locus protein. Characterization and investigation of its melanogenic function.
Kobayashi, T., Urabe, K., Orlow, S. J., Higashi, K., Imokawa, G., Kwon, B. S., Potterf, B., & Hearing, V. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62030-2 · Cited by 138
Fong, L. H., Ruegg, C. L., Brockstedt, D. G., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3113 · Cited by 128
The inability to process a self-peptide allows autoreactive T cells to escape tolerance.
Mamula, M. J. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.2.567 · Cited by 122
Cloning and sequencing of mouse tyrosinase cDNA.
Yamamoto, H., Takeuchi, S., Kudo, T., Makino, K., Nakata, A., Shinoda, T., & Takeuchi, T. (1987) · The Japanese Journal of Genetics · doi:10.1266/jjg.62.271 · Cited by 112
Ke, Y., & Kapp, J. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.3.1179 · Cited by 109
The Imprint of Intrathymic Self-Peptides on the Mature T Cell Receptor Repertoire
Sant’Angelo, D. B., Waterbury, P. G., Cohen, B. E., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80373-8 · Cited by 105
Hu, Q., Walker, C. R. B., Girão, C., Opferman, J. T., Sun, J., Shabanowitz, J., Hunt, D. F., & Ashton‐Rickardt, P. G. (1997) · Immunity · doi:10.1016/s1074-7613(00)80525-7 · Cited by 95
The tyrosinase gene family--interactions of melanogenic proteins to regulate melanogenesis.
WINDER, A. F., Kobayashi, T., Tsukamoto, K., et al. (1994) · PubMed · Cited by 90
Abbas, A. K., Haber, S. I., & Rock, K. L. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.3.1661 · Cited by 84
Kwon, B. S., Halaban, R., Ponnazhagan, S., Kim, K. K., Chintamaneni, C. D., Bennett, D. C., & Pickard, R. T. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.1.154 · Cited by 82
Preparation of Cell Cultures and Vaccinia Virus Stocks
Earl, P. L., Cooper, N., Wyatt, L. S., Moss, B., & Carroll, M. W. (1998) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb1616s43 · Cited by 69
Self-citationThe new vaccines: building viruses that elicit antitumor immunity
Restifo, N. P. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80082-3 · Cited by 68
Self-citationWallace, P. M., Rodgers, J. N., Leytze, G., Johnson, J., & Linsley, P. S. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.11.5885 · Cited by 65
Lipford, G. B., Bauer, S., Wagner, H., et al. (1995) · Vaccine · doi:10.1016/0264-410x(95)93320-9 · Cited by 50
Overwijk, W. W., Surman, D. R., Tsung, K., et al. (1997) · Methods · doi:10.1006/meth.1997.0461 · Cited by 49
Self-citation
Cited by
Adoptive immunotherapy for cancer: harnessing the T cell response
Restifo, N. P., Dudley, M. E., & Rosenberg, S. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3191 · Cited by 1,688
Self-citationDudley, M. E., Wunderlich, J. R., Yang, J. C., Sherry, R. M., Topalian, S. L., Restifo, N. P., Royal, R. E., Kammula, U., White, D. E., Mavroukakis, S. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.240 · Cited by 1,639
Self-citationvan Elsas, A., Hurwitz, A. A., & Allison, J. P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.355 · Cited by 1,020
Gattinoni, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24480 · Cited by 958
Overwijk, W. W., Theoret, M. R., Finkelstein, S. E., Surman, D. R., de Jong, L. A., Vyth-Dreese, F. A., Dellemijn, T. A., Antony, P. A., Spiess, P. J., Palmer, D. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030590 · Cited by 925
Self-citation
Metadata
- Authors
- Overwijk, W. W., Tsung, A., Irvine, K. R., Parkhurst, M. R., Goletz, T. J., Tsung, K., Carroll, M. W., Liu, C., Moss, B., Rosenberg, S. A., & Restifo, N. P.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1998-07-20
- Volume
- 188
- Issue
- 2
- Pages
- 277-286
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2169957856
- Cited by
- 493
- References
- 44
- FWCI
- 9.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.